rs373237152

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2

The NM_025219.3(DNAJC5):​c.525G>A​(p.Pro175Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000012 in 1,576,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

DNAJC5
NM_025219.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.03

Publications

0 publications found
Variant links:
Genes affected
DNAJC5 (HGNC:16235): (DnaJ heat shock protein family (Hsp40) member C5) This gene is a member of the J protein family. J proteins function in many cellular processes by regulating the ATPase activity of 70 kDa heat shock proteins. The encoded protein plays a role in membrane trafficking and protein folding, and has been shown to have anti-neurodegenerative properties. The encoded protein is known to play a role in cystic fibrosis and Huntington's disease. A pseudogene of this gene is located on the short arm of chromosome 8. [provided by RefSeq, Nov 2010]
DNAJC5 Gene-Disease associations (from GenCC):
  • ceroid lipofuscinosis, neuronal, 4 (Kufs type)
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • adult neuronal ceroid lipofuscinosis
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 20-63931496-G-A is Benign according to our data. Variant chr20-63931496-G-A is described in CliVar as Likely_benign. Clinvar id is 457982.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr20-63931496-G-A is described in CliVar as Likely_benign. Clinvar id is 457982.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr20-63931496-G-A is described in CliVar as Likely_benign. Clinvar id is 457982.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr20-63931496-G-A is described in CliVar as Likely_benign. Clinvar id is 457982.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr20-63931496-G-A is described in CliVar as Likely_benign. Clinvar id is 457982.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr20-63931496-G-A is described in CliVar as Likely_benign. Clinvar id is 457982.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr20-63931496-G-A is described in CliVar as Likely_benign. Clinvar id is 457982.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr20-63931496-G-A is described in CliVar as Likely_benign. Clinvar id is 457982.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr20-63931496-G-A is described in CliVar as Likely_benign. Clinvar id is 457982.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr20-63931496-G-A is described in CliVar as Likely_benign. Clinvar id is 457982.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-2.03 with no splicing effect.
BS2
High AC in GnomAdExome4 at 16 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAJC5NM_025219.3 linkc.525G>A p.Pro175Pro synonymous_variant Exon 5 of 5 ENST00000360864.9 NP_079495.1 Q9H3Z4-1Q6AHX3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAJC5ENST00000360864.9 linkc.525G>A p.Pro175Pro synonymous_variant Exon 5 of 5 1 NM_025219.3 ENSP00000354111.4 Q9H3Z4-1

Frequencies

GnomAD3 genomes
AF:
0.0000198
AC:
3
AN:
151304
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000442
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000150
AC:
3
AN:
199918
AF XY:
0.0000185
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000222
Gnomad OTH exome
AF:
0.000191
GnomAD4 exome
AF:
0.0000112
AC:
16
AN:
1425532
Hom.:
0
Cov.:
31
AF XY:
0.00000990
AC XY:
7
AN XY:
706982
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32586
American (AMR)
AF:
0.00
AC:
0
AN:
41596
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25508
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37806
South Asian (SAS)
AF:
0.0000245
AC:
2
AN:
81774
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41976
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5732
European-Non Finnish (NFE)
AF:
0.0000118
AC:
13
AN:
1099306
Other (OTH)
AF:
0.0000169
AC:
1
AN:
59248
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000198
AC:
3
AN:
151304
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
73858
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41094
American (AMR)
AF:
0.00
AC:
0
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3456
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5090
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4762
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10576
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000442
AC:
3
AN:
67798
Other (OTH)
AF:
0.00
AC:
0
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.408
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Neuronal ceroid lipofuscinosis Benign:1
Aug 14, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
1.8
DANN
Benign
0.77
PhyloP100
-2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373237152; hg19: chr20-62562849; API